Effect of Diquafosol on Hyperosmotic Stress-induced Tumor Necrosis Factor-α and Interleukin-6 Expression in Human Corneal Epithelial Cells

PURPOSE: Diquafosol is a pharmaceutical drug used for dry eye treatment with a novel mechanism of action. It is a purinergic P2Y2 receptor agonist that promotes the secretion of tears and healing of corneal epithelial wounds. However, its inhibitory effect on hyperosmotic stress-induced inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeoun-Hee, Yang, In-Jun, Nguyen, Ly Thi Huong, Gum, Sang Il, Yu, Sung, Lee, Gwang Ja, Kim, Bo-Ae, Jung, Jae-Chang, Park, Young Jeung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010473/
https://www.ncbi.nlm.nih.gov/pubmed/32037744
http://dx.doi.org/10.3341/kjo.2019.0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010473/
https://www.ncbi.nlm.nih.gov/pubmed/32037744
http://dx.doi.org/10.3341/kjo.2019.0046

Ejemplares similares